| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | four-way junction DNA binding | 4.34e-06 | 19 | 119 | 4 | GO:0000400 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.11e-05 | 127 | 119 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.77e-05 | 262 | 119 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | forked DNA-dependent helicase activity | 3.52e-05 | 2 | 119 | 2 | GO:0061749 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 1.02e-04 | 41 | 119 | 4 | GO:0000217 | |
| GeneOntologyMolecularFunction | 8-hydroxy-2'-deoxyguanosine DNA binding | 1.05e-04 | 3 | 119 | 2 | GO:1905773 | |
| GeneOntologyMolecularFunction | telomeric G-quadruplex DNA binding | 1.05e-04 | 3 | 119 | 2 | GO:0061849 | |
| GeneOntologyMolecularFunction | Y-form DNA binding | 2.10e-04 | 4 | 119 | 2 | GO:0000403 | |
| GeneOntologyMolecularFunction | telomeric D-loop binding | 2.10e-04 | 4 | 119 | 2 | GO:0061821 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | IPO7 RAPGEF4 OBSCN ADGRB3 RABGAP1 PLEKHG4B SGSM2 HPS1 TBCK GPSM2 PREX1 | 2.27e-04 | 507 | 119 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | IPO7 RAPGEF4 OBSCN ADGRB3 RABGAP1 PLEKHG4B SGSM2 HPS1 TBCK GPSM2 PREX1 | 2.27e-04 | 507 | 119 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | D-loop DNA binding | 5.20e-04 | 6 | 119 | 2 | GO:0062037 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 5.20e-04 | 6 | 119 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | bubble DNA binding | 9.63e-04 | 8 | 119 | 2 | GO:0000405 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.38e-03 | 37 | 119 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.40e-03 | 81 | 119 | 4 | GO:0035254 | |
| GeneOntologyMolecularFunction | oxidized purine DNA binding | 1.54e-03 | 10 | 119 | 2 | GO:0032357 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | RAD51C RAD51D ERCC4 THUMPD3 WRN CHD9 BTAF1 LCMT2 BLM MAP1S SHPRH | 1.65e-03 | 645 | 119 | 11 | GO:0140640 |
| GeneOntologyMolecularFunction | telomeric DNA binding | 1.74e-03 | 40 | 119 | 3 | GO:0042162 | |
| GeneOntologyMolecularFunction | oxidized DNA binding | 1.87e-03 | 11 | 119 | 2 | GO:0032356 | |
| GeneOntologyBiologicalProcess | gamma-delta T cell differentiation | 4.75e-06 | 20 | 119 | 4 | GO:0042492 | |
| GeneOntologyBiologicalProcess | mitotic recombination | 1.67e-05 | 27 | 119 | 4 | GO:0006312 | |
| GeneOntologyBiologicalProcess | gamma-delta T cell activation | 3.79e-05 | 33 | 119 | 4 | GO:0046629 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 4.80e-05 | 35 | 119 | 4 | GO:0032816 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | IL12A STAT5A STAT5B BLM JAG2 PTK2B RSAD2 LMBR1L SCART1 TNFAIP3 PREX1 IL7R | 6.50e-05 | 537 | 119 | 12 | GO:0030098 |
| GeneOntologyBiologicalProcess | T cell differentiation | 7.49e-05 | 382 | 119 | 10 | GO:0030217 | |
| GeneOntologyBiologicalProcess | telomere maintenance via recombination | 8.10e-05 | 15 | 119 | 3 | GO:0000722 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | IL12A THOC5 STAT5A STAT5B BLM JAG2 PTK2B RSAD2 LMBR1L SCART1 TNFAIP3 PREX1 IL7R | 8.39e-05 | 640 | 119 | 13 | GO:1903131 |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 9.86e-05 | 3 | 119 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | luteinization | 9.93e-05 | 16 | 119 | 3 | GO:0001553 | |
| Domain | RQC | 3.96e-05 | 2 | 118 | 2 | SM00956 | |
| Domain | TRPV5/TRPV6 | 3.96e-05 | 2 | 118 | 2 | IPR008344 | |
| Domain | PTPc | 7.63e-05 | 36 | 118 | 4 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.05e-04 | 39 | 118 | 4 | PS50055 | |
| Domain | TPR-like_helical_dom | 1.17e-04 | 233 | 118 | 8 | IPR011990 | |
| Domain | - | 1.18e-04 | 3 | 118 | 2 | 1.10.150.80 | |
| Domain | HRDC | 1.18e-04 | 3 | 118 | 2 | SM00341 | |
| Domain | GPCR_2_brain_angio_inhib | 1.18e-04 | 3 | 118 | 2 | IPR008077 | |
| Domain | RQC_domain | 1.18e-04 | 3 | 118 | 2 | IPR018982 | |
| Domain | HRDC | 1.18e-04 | 3 | 118 | 2 | PS50967 | |
| Domain | RQC | 1.18e-04 | 3 | 118 | 2 | PF09382 | |
| Domain | HRDC | 1.18e-04 | 3 | 118 | 2 | PF00570 | |
| Domain | PTPase_domain | 1.28e-04 | 41 | 118 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 1.28e-04 | 41 | 118 | 4 | PF00102 | |
| Domain | LRRC37AB_C | 2.36e-04 | 4 | 118 | 2 | IPR029423 | |
| Domain | HRDC_dom | 2.36e-04 | 4 | 118 | 2 | IPR002121 | |
| Domain | RecQ_Zn_bind | 2.36e-04 | 4 | 118 | 2 | PF16124 | |
| Domain | LRRC37AB_C | 2.36e-04 | 4 | 118 | 2 | PF14914 | |
| Domain | RecQ_Zn-bd | 2.36e-04 | 4 | 118 | 2 | IPR032284 | |
| Domain | LRRC37_N | 2.36e-04 | 4 | 118 | 2 | IPR032754 | |
| Domain | LRRC37 | 2.36e-04 | 4 | 118 | 2 | PF15779 | |
| Domain | LRRC37A/B-like | 2.36e-04 | 4 | 118 | 2 | IPR015753 | |
| Domain | - | 3.46e-04 | 207 | 118 | 7 | 1.25.40.10 | |
| Domain | HRDC-like | 3.91e-04 | 5 | 118 | 2 | IPR010997 | |
| Domain | DNA_helicase_ATP-dep_RecQ | 3.91e-04 | 5 | 118 | 2 | IPR004589 | |
| Domain | PTPc_motif | 5.27e-04 | 59 | 118 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 5.27e-04 | 59 | 118 | 4 | IPR003595 | |
| Domain | Rad51_DMC1_RadA | 5.84e-04 | 6 | 118 | 2 | IPR033925 | |
| Domain | DNA_recomb/repair_RecA-like | 5.84e-04 | 6 | 118 | 2 | IPR016467 | |
| Domain | Helicase_C | 5.88e-04 | 107 | 118 | 5 | PF00271 | |
| Domain | HELICc | 5.88e-04 | 107 | 118 | 5 | SM00490 | |
| Domain | Helicase_C | 6.14e-04 | 108 | 118 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 6.40e-04 | 109 | 118 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 6.40e-04 | 109 | 118 | 5 | PS51192 | |
| Domain | DEXDc | 6.40e-04 | 109 | 118 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 6.67e-04 | 110 | 118 | 5 | IPR014001 | |
| Domain | STAT_TF_DNA-bd_sub | 8.14e-04 | 7 | 118 | 2 | IPR012345 | |
| Domain | STAT | 8.14e-04 | 7 | 118 | 2 | IPR001217 | |
| Domain | DNA_recomb/repair_Rad51_C | 8.14e-04 | 7 | 118 | 2 | IPR013632 | |
| Domain | STAT_int | 8.14e-04 | 7 | 118 | 2 | SM00964 | |
| Domain | RecA_ATP-bd | 8.14e-04 | 7 | 118 | 2 | IPR020588 | |
| Domain | RECA_2 | 8.14e-04 | 7 | 118 | 2 | PS50162 | |
| Domain | STAT_TF_DNA-bd | 8.14e-04 | 7 | 118 | 2 | IPR013801 | |
| Domain | STAT_bind | 8.14e-04 | 7 | 118 | 2 | PF02864 | |
| Domain | STAT_int | 8.14e-04 | 7 | 118 | 2 | PF02865 | |
| Domain | - | 8.14e-04 | 7 | 118 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 8.14e-04 | 7 | 118 | 2 | PF01017 | |
| Domain | - | 8.14e-04 | 7 | 118 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 8.14e-04 | 7 | 118 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 8.14e-04 | 7 | 118 | 2 | IPR015988 | |
| Domain | - | 8.14e-04 | 7 | 118 | 2 | 2.60.40.630 | |
| Domain | Rad51 | 8.14e-04 | 7 | 118 | 2 | PF08423 | |
| Domain | SNF2_N | 1.07e-03 | 32 | 118 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.07e-03 | 32 | 118 | 3 | PF00176 | |
| Domain | STAT_TF_alpha | 1.08e-03 | 8 | 118 | 2 | IPR013800 | |
| Domain | Tyr_Pase_AS | 1.18e-03 | 73 | 118 | 4 | IPR016130 | |
| Domain | PH_dom-like | 1.54e-03 | 426 | 118 | 9 | IPR011993 | |
| Domain | TPR_7 | 1.72e-03 | 10 | 118 | 2 | PF13176 | |
| Domain | TRP_channel | 2.10e-03 | 11 | 118 | 2 | IPR004729 | |
| Domain | GAIN_dom_N | 2.10e-03 | 11 | 118 | 2 | IPR032471 | |
| Domain | GAIN | 2.10e-03 | 11 | 118 | 2 | PF16489 | |
| Domain | TYR_PHOSPHATASE_1 | 2.16e-03 | 86 | 118 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 2.25e-03 | 87 | 118 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 2.25e-03 | 87 | 118 | 4 | PS50056 | |
| Domain | - | 2.63e-03 | 218 | 118 | 6 | 1.10.10.10 | |
| Domain | - | 2.76e-03 | 92 | 118 | 4 | 3.90.190.10 | |
| Domain | FERM_M | 3.06e-03 | 46 | 118 | 3 | PF00373 | |
| Domain | - | 3.40e-03 | 391 | 118 | 8 | 2.30.29.30 | |
| Domain | Prot-tyrosine_phosphatase-like | 3.59e-03 | 99 | 118 | 4 | IPR029021 | |
| Domain | - | 3.67e-03 | 49 | 118 | 3 | 1.20.80.10 | |
| Domain | TBC | 3.67e-03 | 49 | 118 | 3 | SM00164 | |
| Domain | FERM_central | 3.67e-03 | 49 | 118 | 3 | IPR019748 | |
| Domain | FERM_domain | 3.67e-03 | 49 | 118 | 3 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 3.88e-03 | 50 | 118 | 3 | IPR014352 | |
| Domain | FERM_1 | 3.88e-03 | 50 | 118 | 3 | PS00660 | |
| Domain | FERM_2 | 3.88e-03 | 50 | 118 | 3 | PS00661 | |
| Domain | FERM_3 | 3.88e-03 | 50 | 118 | 3 | PS50057 | |
| Domain | Band_41_domain | 3.88e-03 | 50 | 118 | 3 | IPR019749 | |
| Domain | B41 | 3.88e-03 | 50 | 118 | 3 | SM00295 | |
| Domain | WHTH_DNA-bd_dom | 4.39e-03 | 242 | 118 | 6 | IPR011991 | |
| Domain | Quinoprotein_ADH-like_supfam | 4.58e-03 | 53 | 118 | 3 | IPR011047 | |
| Domain | RabGAP-TBC | 4.58e-03 | 53 | 118 | 3 | PF00566 | |
| Domain | Rab-GTPase-TBC_dom | 5.08e-03 | 55 | 118 | 3 | IPR000195 | |
| Domain | TBC_RABGAP | 5.08e-03 | 55 | 118 | 3 | PS50086 | |
| Domain | Ion_trans_dom | 5.93e-03 | 114 | 118 | 4 | IPR005821 | |
| Domain | Ion_trans | 5.93e-03 | 114 | 118 | 4 | PF00520 | |
| Domain | VWC_out | 6.31e-03 | 19 | 118 | 2 | SM00215 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.22e-06 | 16 | 86 | 4 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.22e-06 | 16 | 86 | 4 | MM1420 | |
| Pathway | WP_IL7_SIGNALING | 1.48e-05 | 25 | 86 | 4 | M39499 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 1.74e-05 | 26 | 86 | 4 | MM15297 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA | 2.04e-05 | 27 | 86 | 4 | M27586 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 2.55e-05 | 10 | 86 | 3 | MM15618 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 4.63e-05 | 12 | 86 | 3 | M27893 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 5.85e-05 | 35 | 86 | 4 | MM15293 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 7.31e-05 | 37 | 86 | 4 | M27583 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 7.50e-05 | 116 | 86 | 6 | MM15294 | |
| Pathway | WP_FOXP3_IN_COVID19 | 9.46e-05 | 15 | 86 | 3 | M42573 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 9.46e-05 | 15 | 86 | 3 | MM14536 | |
| Pathway | WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION | 1.16e-04 | 16 | 86 | 3 | M48107 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 1.33e-04 | 43 | 86 | 4 | M27588 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 1.33e-04 | 43 | 86 | 4 | MM15864 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 1.59e-04 | 45 | 86 | 4 | M47408 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 2.11e-04 | 140 | 86 | 6 | M27584 | |
| Pathway | REACTOME_DISEASES_OF_DNA_REPAIR | 2.59e-04 | 51 | 86 | 4 | M29854 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 2.65e-04 | 146 | 86 | 6 | MM15292 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 3.55e-04 | 23 | 86 | 3 | M47904 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 3.64e-04 | 5 | 86 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 3.64e-04 | 5 | 86 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 3.64e-04 | 5 | 86 | 2 | M49006 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 4.55e-04 | 59 | 86 | 4 | MM15283 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 5.43e-04 | 6 | 86 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 5.43e-04 | 6 | 86 | 2 | MM15621 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 5.97e-04 | 170 | 86 | 6 | M27582 | |
| Pathway | KEGG_HOMOLOGOUS_RECOMBINATION | 6.43e-04 | 28 | 86 | 3 | M11675 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 7.57e-04 | 7 | 86 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 7.57e-04 | 7 | 86 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 7.57e-04 | 7 | 86 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 7.57e-04 | 7 | 86 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 7.57e-04 | 7 | 86 | 2 | M27907 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 8.71e-04 | 70 | 86 | 4 | M27570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION | 1.01e-03 | 8 | 86 | 2 | M47746 | |
| Pathway | REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM | 1.01e-03 | 8 | 86 | 2 | MM14766 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.25e-03 | 77 | 86 | 4 | M27226 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 1.25e-03 | 35 | 86 | 3 | MM15144 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.29e-03 | 9 | 86 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.29e-03 | 9 | 86 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.29e-03 | 9 | 86 | 2 | M8066 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 1.35e-03 | 36 | 86 | 3 | MM15281 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 1.35e-03 | 36 | 86 | 3 | M542 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 1.45e-03 | 136 | 86 | 5 | M42547 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 1.47e-03 | 37 | 86 | 3 | M27568 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.60e-03 | 10 | 86 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 1.60e-03 | 10 | 86 | 2 | M41731 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 1.95e-03 | 11 | 86 | 2 | M27195 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAD51_DSDNA_DESTABILIZATION | 1.95e-03 | 11 | 86 | 2 | M47894 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.95e-03 | 11 | 86 | 2 | MM15578 | |
| Pathway | WP_IL2_SIGNALING | 2.12e-03 | 42 | 86 | 3 | M39536 | |
| Pathway | REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM | 2.33e-03 | 12 | 86 | 2 | M27088 | |
| Pathway | REACTOME_DNA_REPAIR | 2.40e-03 | 301 | 86 | 7 | MM15433 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 2.42e-03 | 44 | 86 | 3 | M1012 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 2.57e-03 | 155 | 86 | 5 | M17411 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 16273100 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 7719938 | ||
| Pubmed | STAT5 activation underlies IL7 receptor-dependent B cell development. | 1.68e-07 | 4 | 122 | 3 | 15067053 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 SZT2 UBE3B OBSCN ADGRB2 BTAF1 SMG5 PTCH1 TINAGL1 JAG2 PIAS4 MAP1S SGSM2 ANKRD11 AP1G2 TNFAIP3 PREX1 | 3.39e-07 | 1105 | 122 | 17 | 35748872 |
| Pubmed | Stat5a/b are essential for normal lymphoid development and differentiation. | 4.19e-07 | 5 | 122 | 3 | 16418296 | |
| Pubmed | Autophagic Flux Is Regulated by Interaction Between the C-terminal Domain of PATCHED1 and ATG101. | 4.19e-07 | 5 | 122 | 3 | 29453315 | |
| Pubmed | Direct interaction between Kit and the interleukin-7 receptor. | 4.19e-07 | 5 | 122 | 3 | 17554063 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 12975363 | ||
| Pubmed | SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. | 1.46e-06 | 7 | 122 | 3 | 10490100 | |
| Pubmed | 3.48e-06 | 9 | 122 | 3 | 19946273 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJC13 OBSCN CHD9 BTAF1 RABGAP1 ATP10A STT3A STAT5B JAG2 PLEKHG4B PIAS4 PTPN4 HOXB6 SGSM2 NUP210 TBCK SHPRH ANKRD11 | 4.60e-06 | 1489 | 122 | 18 | 28611215 |
| Pubmed | 4.96e-06 | 10 | 122 | 3 | 20974963 | ||
| Pubmed | 4.96e-06 | 10 | 122 | 3 | 32103006 | ||
| Pubmed | 4.96e-06 | 10 | 122 | 3 | 17182565 | ||
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 6.72e-06 | 198 | 122 | 7 | 20881960 | |
| Pubmed | 8.92e-06 | 136 | 122 | 6 | 25429064 | ||
| Pubmed | TTC28 RAPGEF4 ADGRB3 HLCS CHD9 OAT SMG5 STAT5B NELL1 MAP1S SGSM2 GLUL DNM3 DLEU7 GPSM2 PREX1 | 1.14e-05 | 1285 | 122 | 16 | 35914814 | |
| Pubmed | STAT5 is required for thymopoiesis in a development stage-specific manner. | 1.17e-05 | 13 | 122 | 3 | 15294943 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23151802 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26999798 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18285457 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 1.22e-05 | 2 | 122 | 2 | 31443474 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20178461 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12377952 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22354706 | ||
| Pubmed | Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane. | 1.22e-05 | 2 | 122 | 2 | 16564089 | |
| Pubmed | Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. | 1.22e-05 | 2 | 122 | 2 | 19295174 | |
| Pubmed | Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity. | 1.22e-05 | 2 | 122 | 2 | 23968883 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12390878 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 1.22e-05 | 2 | 122 | 2 | 21127177 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16289657 | ||
| Pubmed | The Werner and Bloom syndrome proteins catalyze regression of a model replication fork. | 1.22e-05 | 2 | 122 | 2 | 17115688 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25552366 | ||
| Pubmed | Attenuation of IL-7 receptor signaling is not required for allelic exclusion. | 1.22e-05 | 2 | 122 | 2 | 16517702 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25470773 | ||
| Pubmed | TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice. | 1.22e-05 | 2 | 122 | 2 | 30916584 | |
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 1.22e-05 | 2 | 122 | 2 | 21431790 | |
| Pubmed | Loss of Blm enhances basal cell carcinoma and rhabdomyosarcoma tumorigenesis in Ptch1+/- mice. | 1.22e-05 | 2 | 122 | 2 | 19995795 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 28500076 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21826656 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 7720707 | ||
| Pubmed | Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer. | 1.22e-05 | 2 | 122 | 2 | 33657816 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16565876 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 1.22e-05 | 2 | 122 | 2 | 27264955 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26057125 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22159083 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20008792 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12218411 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 33199496 | ||
| Pubmed | Colocalization, physical, and functional interaction between Werner and Bloom syndrome proteins. | 1.22e-05 | 2 | 122 | 2 | 11919194 | |
| Pubmed | Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6. | 1.22e-05 | 2 | 122 | 2 | 16705151 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16502315 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18028256 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12217382 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 31599926 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 10594041 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21036145 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 10486277 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20405023 | ||
| Pubmed | Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5. | 1.22e-05 | 2 | 122 | 2 | 16622421 | |
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 1.22e-05 | 2 | 122 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 1.22e-05 | 2 | 122 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 1.22e-05 | 2 | 122 | 2 | 30377054 | |
| Pubmed | A single amino acid mutation results in a rapid inactivation of epithelial calcium channels. | 1.22e-05 | 2 | 122 | 2 | 11846401 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 1.22e-05 | 2 | 122 | 2 | 32790723 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18492722 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 10066807 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 10835485 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 35464049 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 1.22e-05 | 2 | 122 | 2 | 23773921 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 1.22e-05 | 2 | 122 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 1.22e-05 | 2 | 122 | 2 | 24878107 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12847485 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12835478 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24761864 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 1.22e-05 | 2 | 122 | 2 | 24497979 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21602932 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 1.22e-05 | 2 | 122 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 1.22e-05 | 2 | 122 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 1.22e-05 | 2 | 122 | 2 | 10486314 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 1.22e-05 | 2 | 122 | 2 | 24497923 | |
| Pubmed | Potent inhibition of werner and bloom helicases by DNA minor groove binding drugs. | 1.22e-05 | 2 | 122 | 2 | 10871376 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12077127 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24335105 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 1.22e-05 | 2 | 122 | 2 | 29460051 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 34923718 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24592736 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 28606561 | ||
| Pubmed | BLM helicase facilitates telomere replication during leading strand synthesis of telomeres. | 1.22e-05 | 2 | 122 | 2 | 26195664 | |
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 1.22e-05 | 2 | 122 | 2 | 12393407 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12039059 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21178171 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 1.22e-05 | 2 | 122 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 1.22e-05 | 2 | 122 | 2 | 16775227 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 4.30e-05 | 3 | 69 | 2 | 912 | |
| GeneFamily | RecQ like helicases | 1.42e-04 | 5 | 69 | 2 | 1049 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 9.17e-04 | 50 | 69 | 3 | 1293 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 2.11e-03 | 18 | 69 | 2 | 812 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 2.61e-03 | 20 | 69 | 2 | 548 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.88e-03 | 21 | 69 | 2 | 813 | |
| GeneFamily | Transient receptor potential cation channels | 5.09e-03 | 28 | 69 | 2 | 249 | |
| GeneFamily | Autophagy related | 7.02e-03 | 33 | 69 | 2 | 1022 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 9.69e-03 | 115 | 69 | 3 | 769 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.51e-08 | 182 | 120 | 8 | f30e5a21b49f30b82e2b6f1fd2daefd805a40083 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-MAIT|COVID-19_Severe / Disease group, lineage and cell class | 3.51e-08 | 182 | 120 | 8 | 19045db5c726c06ec6e4feb4311633c8164ddb3c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.51e-08 | 182 | 120 | 8 | cccac9f85825f4e310b86e37ee6320769a670501 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.51e-08 | 182 | 120 | 8 | 1444cdc4522a70a40d697ccadf54cf26d327ade0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.51e-08 | 182 | 120 | 8 | 49eced222e8f90c2b59bcc7d56b62c3e703fcce5 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.00e-08 | 199 | 120 | 8 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue | 4.20e-07 | 171 | 120 | 7 | 2977cffc146470733b5cfd8a1aa80d9346d4804d | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / Disease condition and Cell class | 5.30e-07 | 177 | 120 | 7 | 8eb69041f482b58325e3539f607923f7b1fa5977 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT|bone_marrow / Manually curated celltypes from each tissue | 5.50e-07 | 178 | 120 | 7 | 7ac71e245864be2e8daecf555ff68235bd05827c | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.39e-07 | 182 | 120 | 7 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-07 | 186 | 120 | 7 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILC3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.67e-07 | 187 | 120 | 7 | a037631a01d2cce088e6522dceeb1eee806522a1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.67e-07 | 187 | 120 | 7 | 42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue | 8.23e-07 | 189 | 120 | 7 | ac2995e599f3d1813218479dc515b1d612c0ef8b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 8.53e-07 | 190 | 120 | 7 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT|bone_marrow / Manually curated celltypes from each tissue | 8.83e-07 | 191 | 120 | 7 | 7a28905ad504979497836e87df81d529e675ce78 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.01e-06 | 195 | 120 | 7 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-MAIT|COVID-19_Severe / Disease, condition lineage and cell class | 1.20e-06 | 200 | 120 | 7 | b8cfccecff9900aee323c40e771c94e560b8c488 | |
| ToppCell | control-MAIT|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.20e-06 | 200 | 120 | 7 | aeea4bda2e38cc6db571ed2b47ce022d637619bd | |
| ToppCell | severe-MAIT|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.20e-06 | 200 | 120 | 7 | 1daf43f1bdd49585dce5e957820554d7f3c1bd4a | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.80e-06 | 135 | 120 | 6 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.64e-06 | 159 | 120 | 6 | 2fb1d2ff52920aeb48d048cf29f0cd45f944a73d | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 5.55e-06 | 164 | 120 | 6 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.31e-06 | 176 | 120 | 6 | 03d194c9814e12802cd932afade69e868814cb78 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.31e-06 | 176 | 120 | 6 | 238244294d08975df6bfa26b2b437db3654408ae | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-06 | 177 | 120 | 6 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.86e-06 | 178 | 120 | 6 | a62137d7f5fac16619f8a02844cdb0be7a794bf2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.44e-06 | 180 | 120 | 6 | 7a9aa96fb8035020640cc7d3df0c41c730516c6f | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 184 | 120 | 6 | 3e9d75af578297950e469f23fb2d28393a2feef8 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 185 | 120 | 6 | 8314dc608bc837df3037e89afd9db39737374ebc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-05 | 187 | 120 | 6 | f1ba41f2ec703251a81c46e08d45e70210f298e7 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 120 | 6 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 120 | 6 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 120 | 6 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 120 | 6 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.21e-05 | 188 | 120 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 188 | 120 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 189 | 120 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 189 | 120 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 1.25e-05 | 189 | 120 | 6 | afe3a4fe7c10eeeb7064129778d940269c9acbef | |
| ToppCell | Severe-MAIT|World / Disease group and Cell class | 1.28e-05 | 190 | 120 | 6 | 7a92e0d6a021be23125495927b8571e25c83204a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 193 | 120 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 193 | 120 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 193 | 120 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | 1.40e-05 | 193 | 120 | 6 | 7c14bc481ed38378b9e6a85f768a1e526c5997e6 | |
| ToppCell | Control-MAIT|Control / Disease condition and Cell class | 1.44e-05 | 194 | 120 | 6 | ed99f8bff6766795fc396990604366f49ff58181 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-05 | 195 | 120 | 6 | c7b54b210cc2c8ddaefebfba74381adb2ca698b8 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-05 | 195 | 120 | 6 | e173a713d273b135db4f71bdcaada3b0e55d74f1 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 195 | 120 | 6 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-05 | 195 | 120 | 6 | 59164d115a0928cc9b79c7661c7190ad695f9d80 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-05 | 195 | 120 | 6 | a8fd42ff6c2bd80d0e3f20fe3bbf7d113b399df1 | |
| ToppCell | (4)_Endothelial_cells-(41)_EC-arteriolar|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.58e-05 | 197 | 120 | 6 | 482e3f8926880afed88ed37553ed2b5ed58b8c99 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD8+_Tcm|Bac-SEP / Disease, condition lineage and cell class | 1.62e-05 | 198 | 120 | 6 | 84a07dea22b7771b34118729607b48c2d75df870 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 198 | 120 | 6 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | (220)_CD8+_Cytotoxic_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.62e-05 | 198 | 120 | 6 | 2af389b8ea5767ba56fe64d719afe5be3f9a43ec | |
| ToppCell | mild-MAIT|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.72e-05 | 200 | 120 | 6 | 1e3ef15ce48b9a19a6ac3e08ea0234a9376e6596 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.72e-05 | 200 | 120 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.72e-05 | 200 | 120 | 6 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-05 | 128 | 120 | 5 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 4.15e-05 | 142 | 120 | 5 | 1175d4390d204ffa3a2d2fe24486f85d3b639b72 | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 4.90e-05 | 147 | 120 | 5 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | MS-CD4-CD8_2|MS / Condition, Cell_class and T cell subcluster | 5.22e-05 | 149 | 120 | 5 | 08fb6be5599c5988890c851ce5ac6781c319948e | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 5.74e-05 | 152 | 120 | 5 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 6.30e-05 | 155 | 120 | 5 | 83430a64c2cb5ad29caa3dacba76c28dd204ac40 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-MAIT|Lung / Manually curated celltypes from each tissue | 6.30e-05 | 155 | 120 | 5 | 72c61be0a8d3ee10600a33c58fb01c35fd3f14d4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 155 | 120 | 5 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.50e-05 | 156 | 120 | 5 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | VE-CD8-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 7.32e-05 | 160 | 120 | 5 | 255d2a150bfe19ee3d4d34533feb9c37ce73d225 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_CTL|URO / Disease, Lineage and Cell Type | 7.77e-05 | 162 | 120 | 5 | 1afeeb17e263cf625a4f285203cf82f973735193 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.99e-05 | 163 | 120 | 5 | 11cc18f36604d9a5f4e7fb8626a8f0fb141da5e1 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.71e-05 | 166 | 120 | 5 | 26f3d5e5e30b63b09b89cda23c423d12d887631f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Th1|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.96e-05 | 167 | 120 | 5 | 9c55ec8f70b86d4d3d5c2a6ecd9bff2dafe68c11 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 167 | 120 | 5 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.22e-05 | 168 | 120 | 5 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.22e-05 | 168 | 120 | 5 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | Control-Lymphocyte-T_NK-MAIT|Control / Disease, Lineage and Cell Type | 9.48e-05 | 169 | 120 | 5 | 8c2aac193a9c500f01a99a2ee530839c851b6222 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 171 | 120 | 5 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | Healthy_donor-MAIT|World / disease group, cell group and cell class (v2) | 1.03e-04 | 172 | 120 | 5 | 6524eb2be1c78700ad367e62624a4d7eb48b54f0 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 173 | 120 | 5 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 174 | 120 | 5 | ecee7e012ccd7876fb9df8aa939f8eb05b0c2b13 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 174 | 120 | 5 | 693fc31bed0f560644e419fa70ef09f863425416 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.09e-04 | 174 | 120 | 5 | 5e6050d20a5b27640f6a200441125b8ceba123c8 | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 1.09e-04 | 174 | 120 | 5 | 51be6f29308c01593978cbee92114151a5916c9c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-04 | 175 | 120 | 5 | b85279b9efd72d7074c4226d50ce139a38c0e1c1 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 1.15e-04 | 176 | 120 | 5 | 25c197d3b39deffa4801a1d12cdb54320cbae509 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 176 | 120 | 5 | ed7ba2a3af3b060dec98b60f09f96000a67f7e63 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 176 | 120 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 176 | 120 | 5 | e788c7e0b2bfde31fddbf9e04d07140f8b964857 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_CTXN3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 177 | 120 | 5 | 96d639407f79669f3990138793d157b94273581c | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.18e-04 | 177 | 120 | 5 | 0830944c43de300815831a9e2b2fce40965e7d12 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.18e-04 | 177 | 120 | 5 | e63d01c7fce4fa1256212fa7e95f74281edb3a01 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 177 | 120 | 5 | baf78a8dad55f124f56585f88b10b58c0269680f | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.21e-04 | 178 | 120 | 5 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 179 | 120 | 5 | 820289f14ecf165758529c236bb220bb1a744f02 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 179 | 120 | 5 | e5f781d35449628a7f356d71e26231dd63482eec | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-04 | 179 | 120 | 5 | b8bc03f60a7ac76ea6ee90d0512f0dc1d1d2a087 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Th17|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-04 | 179 | 120 | 5 | 61472d75f4a3c4374eeb55ef79982ae4054dadaa | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 179 | 120 | 5 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 179 | 120 | 5 | b0585a8e596c3d8e434af943e65207fa5877600d | |
| Computational | Genes in the cancer module 318. | 4.84e-05 | 28 | 79 | 4 | MODULE_318 | |
| Disease | Basal cell carcinoma | 1.03e-05 | 11 | 119 | 3 | C0007117 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 1.37e-05 | 12 | 119 | 3 | EFO_0800453 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 1.78e-05 | 13 | 119 | 3 | OBA_2045082 | |
| Disease | neutrophil count | IPPK SCFD2 DNAJC13 SPATA6L RAPSN IPO7 TTC28 TTC39C CHD9 GCKR JAG2 PTPN14 LINGO1 ANKRD11 DNM3 TNFAIP3 PREX1 | 4.03e-05 | 1382 | 119 | 17 | EFO_0004833 |
| Disease | Hereditary breast ovarian cancer syndrome | 9.63e-05 | 4 | 119 | 2 | cv:C0677776 | |
| Disease | Acute monocytic leukemia | 1.55e-04 | 26 | 119 | 3 | C0023465 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 1.60e-04 | 5 | 119 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | 1-myristoyl-2-docosahexaenoyl-GPC (14:0/22:6) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800454 | |
| Disease | 1-myristoyl-2-linoleoyl-GPC (14:0/18:2) measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0800452 | |
| Disease | Werner syndrome (implicated_via_orthology) | 1.60e-04 | 5 | 119 | 2 | DOID:5688 (implicated_via_orthology) | |
| Disease | Malignant tumor of breast | 1.74e-04 | 27 | 119 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 1.74e-04 | 27 | 119 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 1.74e-04 | 27 | 119 | 3 | cv:C0346153 | |
| Disease | Miller Dieker syndrome | 2.16e-04 | 29 | 119 | 3 | C0265219 | |
| Disease | triacylglycerol 56:7 measurement | 2.16e-04 | 29 | 119 | 3 | EFO_0010434 | |
| Disease | 2-myristoyl-GPC (14:0) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800242 | |
| Disease | 1-myristoyl-GPC (14:0) measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0800221 | |
| Disease | gondoic acid measurement | 2.39e-04 | 6 | 119 | 2 | EFO_0007975 | |
| Disease | platelet measurement | 2.98e-04 | 315 | 119 | 7 | EFO_0005036 | |
| Disease | neuropilin-1 measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0020603 | |
| Disease | myeloid white cell count | IPPK SCFD2 DNAJC13 RAPSN TTC28 GCKR JAG2 PTK2B MED12L TNFAIP3 PREX1 IL7R | 4.14e-04 | 937 | 119 | 12 | EFO_0007988 |
| Disease | Crohn's disease | 4.32e-04 | 441 | 119 | 8 | EFO_0000384 | |
| Disease | 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) measurement | 4.44e-04 | 8 | 119 | 2 | EFO_0800455 | |
| Disease | phosphatidylcholine 32:1 measurement | 4.87e-04 | 38 | 119 | 3 | EFO_0010373 | |
| Disease | body weight | IPPK RAPSN ADGRB3 RABGAP1 GCKR PTCH1 PTPRT NELL1 PTPN14 LINGO1 PTPRN DNM3 DLEU7 EIF2AK3 | 5.69e-04 | 1261 | 119 | 14 | EFO_0004338 |
| Disease | platelet-to-lymphocyte ratio | 6.94e-04 | 363 | 119 | 7 | EFO_0008446 | |
| Disease | triacylglycerol 56:6 measurement | 7.02e-04 | 43 | 119 | 3 | EFO_0010433 | |
| Disease | creatinine measurement | DNAJC13 RAPSN OBSCN CHD9 BTAF1 GCKR ADARB2 TINAGL1 JAG2 NELL1 PTPN14 ANKRD11 | 7.03e-04 | 995 | 119 | 12 | EFO_0004518 |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 7.11e-04 | 10 | 119 | 2 | EFO_0800608 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] measurement | 7.11e-04 | 10 | 119 | 2 | EFO_0800507 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 7.11e-04 | 10 | 119 | 2 | EFO_0800464 | |
| Disease | level of Sterol ester (27:1/18:3) in blood serum | 7.11e-04 | 10 | 119 | 2 | OBA_2045193 | |
| Disease | linguistic error measurement, specific language impairment | 7.11e-04 | 10 | 119 | 2 | EFO_0007798, EFO_1001510 | |
| Disease | level of phosphatidylcholine | 7.11e-04 | 10 | 119 | 2 | OBA_2040179 | |
| Disease | coffee consumption measurement, tea consumption measurement | 7.51e-04 | 44 | 119 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | ornithine measurement | 7.51e-04 | 44 | 119 | 3 | EFO_0009776 | |
| Disease | Multiple Sclerosis | 8.02e-04 | 45 | 119 | 3 | C0026769 | |
| Disease | Multiple Sclerosis, Acute Fulminating | 8.02e-04 | 45 | 119 | 3 | C0751324 | |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 8.66e-04 | 11 | 119 | 2 | EFO_0800269 | |
| Disease | Cognitive impairment | 8.66e-04 | 11 | 119 | 2 | HP_0100543 | |
| Disease | hippocampal CA1 volume | 9.69e-04 | 48 | 119 | 3 | EFO_0009394 | |
| Disease | peptide measurement | 1.01e-03 | 109 | 119 | 4 | EFO_0010520 | |
| Disease | phosphatidylcholine 34:4 measurement | 1.04e-03 | 12 | 119 | 2 | EFO_0010378 | |
| Disease | triacylglycerol 53:2 measurement | 1.04e-03 | 12 | 119 | 2 | EFO_0021484 | |
| Disease | cholesteryl ester 24:5 measurement | 1.04e-03 | 12 | 119 | 2 | EFO_0021448 | |
| Disease | level of Phosphatidylcholine (16:0_20:2) in blood serum | 1.04e-03 | 12 | 119 | 2 | OBA_2045074 | |
| Disease | obsolete_red blood cell distribution width | ATG101 CFAP251 DNAJC13 RAPSN TTC28 UBE3B HCN3 LRRC37A2 SMG5 GCKR ZBTB24 CCNF WDR20 NUP210 | 1.08e-03 | 1347 | 119 | 14 | EFO_0005192 |
| Disease | body surface area | 1.21e-03 | 643 | 119 | 9 | EFO_0022196 | |
| Disease | cancer | 1.22e-03 | 400 | 119 | 7 | MONDO_0004992 | |
| Disease | Sjogren's Syndrome | 1.22e-03 | 13 | 119 | 2 | C1527336 | |
| Disease | Sicca Syndrome | 1.22e-03 | 13 | 119 | 2 | C0086981 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 1.22e-03 | 13 | 119 | 2 | OBA_2045072 | |
| Disease | lymphocyte measurement | 1.31e-03 | 117 | 119 | 4 | EFO_0803546 | |
| Disease | forced expiratory volume | PTCH1 ZBTB24 RYR2 MFAP2 HOXB6 DNM3 DLEU7 EIF2AK3 PREX1 HERC5 | 1.37e-03 | 789 | 119 | 10 | EFO_0004314 |
| Disease | Metabolic Bone Disorder | 1.42e-03 | 14 | 119 | 2 | C0005944 | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 1.42e-03 | 14 | 119 | 2 | OBA_2045143 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.42e-03 | 14 | 119 | 2 | C0677776 | |
| Disease | Osteopenia | 1.64e-03 | 15 | 119 | 2 | C0029453 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 1.64e-03 | 15 | 119 | 2 | OBA_2045165 | |
| Disease | irritable bowel syndrome symptom measurement | 1.68e-03 | 58 | 119 | 3 | EFO_0021536 | |
| Disease | phosphatidylcholine 32:2 measurement | 1.87e-03 | 16 | 119 | 2 | EFO_0010374 | |
| Disease | Tinnitus | 1.93e-03 | 130 | 119 | 4 | HP_0000360 | |
| Disease | psoriasis vulgaris | 1.94e-03 | 61 | 119 | 3 | EFO_1001494 | |
| Disease | primary biliary cirrhosis | 2.10e-03 | 133 | 119 | 4 | EFO_1001486 | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 2.11e-03 | 17 | 119 | 2 | OBA_2045063 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.54e-03 | 67 | 119 | 3 | C3463824 | |
| Disease | exercise test | 2.92e-03 | 20 | 119 | 2 | EFO_0004328 | |
| Disease | saturated fatty acids to total fatty acids percentage | 3.22e-03 | 21 | 119 | 2 | EFO_0022305 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 3.22e-03 | 21 | 119 | 2 | OBA_2045083 | |
| Disease | breast cancer (is_implicated_in) | 3.24e-03 | 150 | 119 | 4 | DOID:1612 (is_implicated_in) | |
| Disease | triacylglycerol 54:6 measurement | 3.53e-03 | 22 | 119 | 2 | EFO_0010424 | |
| Disease | phosphatidylcholine 34:3 measurement | 3.53e-03 | 22 | 119 | 2 | EFO_0010377 | |
| Disease | Granulomatous Slack Skin | 3.53e-03 | 22 | 119 | 2 | C0376407 | |
| Disease | S-6-hydroxywarfarin measurement | 3.85e-03 | 368 | 119 | 6 | EFO_0803326 | |
| Disease | BMI-adjusted fasting blood glucose measurement | 3.86e-03 | 23 | 119 | 2 | EFO_0008036 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 3.86e-03 | 23 | 119 | 2 | C0079773 | |
| Disease | insulin sensitivity measurement | 3.86e-03 | 23 | 119 | 2 | EFO_0004471 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 3.86e-03 | 23 | 119 | 2 | OBA_2045158 | |
| Disease | arginine measurement | 3.86e-03 | 23 | 119 | 2 | EFO_0020990 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVITAVHCFLRREVQ | 1196 | O60241 | |
| VHCFLRREVQDVVKC | 1201 | O60241 | |
| RCRLALVTAFVAQIH | 2386 | Q96N23 | |
| LIVSCEQEILRVHCR | 2526 | Q6UB99 | |
| EQEILRVHCRAARTI | 2531 | Q6UB99 | |
| ASVQCEHRELFIRHI | 146 | A6NC98 | |
| IEERERSVCLHIFLQ | 906 | Q9NZJ5 | |
| VHCILRREVQDAFRC | 1146 | O60242 | |
| EVIQKECAHIRASFR | 26 | O75843 | |
| LENEVIECHRIRFCN | 916 | Q96PN6 | |
| KEIHVGDFVRLRCNE | 161 | O60312 | |
| IREERQRVLLYVCAH | 266 | Q8TBY9 | |
| VCQEYLARNARIVHL | 396 | Q8N436 | |
| VDRVVDLATACIQHL | 166 | O43502 | |
| AEALRRIQVVHAFDI | 161 | O75771 | |
| LLSRHVVCQVDFIIR | 301 | A0A096LPK9 | |
| LQRELRAHVVRFHEC | 341 | Q13702 | |
| LVVNDCHAEVVARRA | 426 | Q9NS39 | |
| LVVAHAQRCVVLRFL | 21 | Q9H8X2 | |
| ARDRQHTEVVCNILL | 21 | P29074 | |
| VQLERCRVVAQDSHF | 796 | Q8TDY2 | |
| ELFRIHVFRCEIQEA | 241 | Q9Y3P9 | |
| HVFRCEIQEAVSRIL | 246 | Q9Y3P9 | |
| VLRCDAIVDLIHDIQ | 106 | Q8TEM1 | |
| FAIARRLAQDRAHVV | 46 | Q6PKH6 | |
| LVALAVALCVRQHAR | 591 | Q16849 | |
| VEILCEHPRFRVFVD | 126 | Q3ZCW2 | |
| AIVCCQRHLDISREL | 121 | P81274 | |
| HLVDEEFFQRVRALC | 961 | Q66K74 | |
| LIARQCFSLEDVVQH | 1091 | Q86YW9 | |
| LIVICCHRRSLQEDE | 1601 | A6NM11 | |
| LIVICCHRRSLQEDE | 1601 | A6NMS7 | |
| VEFRNICSHLALQIE | 156 | Q6UYE1 | |
| VRVLATAHRQLQDIC | 186 | Q8TDU6 | |
| HVAHLELQIRVRCDE | 186 | Q9Y219 | |
| VVVCEADTGRIHRFV | 146 | Q9Y5P6 | |
| LGRFHEVRSVLADCV | 176 | P50747 | |
| RLCEETERIVANHIR | 451 | Q9UQ16 | |
| EDRHCIRENIVEAII | 86 | O95373 | |
| LLSRHVVCQVDFIIR | 301 | Q8N0Y3 | |
| RRCTEIVAIDALHFR | 816 | Q86W56 | |
| VVHLDFRAALETCER | 46 | Q7Z412 | |
| QDRAVLCHRKRFVAV | 51 | Q96FE5 | |
| CQIHRVDDIQARDEV | 306 | P16871 | |
| CILLHAFRIRAVTID | 196 | P29459 | |
| IDRCVEAFVEVGRLH | 401 | O75600 | |
| LRAVAVESIHRFCVQ | 351 | Q7Z3U7 | |
| REEIINFTCRGLVAH | 411 | Q9P1Z3 | |
| HGLADRVINCREVLE | 801 | Q9C091 | |
| LLLHVDCNRIYERVI | 161 | Q92832 | |
| ADIDEDIIHRIFRIC | 1306 | O14522 | |
| CLLEILRTFERAHQV | 291 | Q14397 | |
| RIEIAHALCLTERQI | 176 | P17509 | |
| ELLHRLNFFVEVCRR | 596 | Q9UII4 | |
| HFICIRFEALTEARQ | 5056 | Q5VST9 | |
| VHVVALATEQERQIC | 126 | Q9BSB4 | |
| HDVEVLERNFQTILC | 186 | Q6ICH7 | |
| IIHARALVRECLAET | 106 | O75956 | |
| RQLNEHDVEIICRAL | 1521 | Q3L8U1 | |
| ERLVHRAVCQIKIFC | 386 | Q8TE85 | |
| RKLLARFVIDEAHCV | 786 | P54132 | |
| VLQLRVHTFAACAVV | 851 | O14981 | |
| AVVHESLRAECQLQR | 166 | P41002 | |
| FEDAVAHICRINRIL | 2776 | Q9UFH2 | |
| IVDAARHCDLQVRID | 471 | Q14152 | |
| IEVRVHCQLVRLFAR | 511 | Q8TCT0 | |
| HCQLVRLFARGIEEN | 516 | Q8TCT0 | |
| TEAVLHEVLRFCNIV | 361 | Q6VVX0 | |
| FHELIRQVSVDCADR | 266 | Q5T1B0 | |
| RVIHALSENELCVRA | 2071 | O75165 | |
| NVRFRCFLAKVHELE | 61 | Q5TF58 | |
| ESINCVHRDIAVRNI | 541 | Q14289 | |
| ELCIEALERHVIQAV | 181 | Q92902 | |
| AVHVVERSCRLRVDA | 51 | O43304 | |
| CQVRHRIEAIVAFSD | 1916 | Q92736 | |
| ICVRTVCAHEELLRA | 136 | P55001 | |
| HIVVLCRGRAFVFDV | 191 | Q9UKG9 | |
| RLACADIRVHQAVLY | 191 | Q8NGQ4 | |
| ARFILHRVCEDFGVI | 221 | P15104 | |
| REFHEFIVLCQLTLQ | 211 | A6NKG5 | |
| EAERHVLRLQFFVVL | 3181 | Q5T011 | |
| IVLREDNCHFLRVDK | 436 | Q8WZA2 | |
| IRECVFLHRNRFLEE | 131 | Q8N4H0 | |
| HFRIVRGVNECDIES | 436 | Q9GZM7 | |
| HQACIDENLEVVRFL | 106 | Q9BZL4 | |
| AVVEAVHRLDLILCN | 26 | Q9UPR3 | |
| FERFLERHKEVSCLV | 276 | Q8WXG1 | |
| VREQLFHERIRECII | 11 | Q6UX01 | |
| CLEAVAQRLELRETH | 46 | Q15678 | |
| LRRDAIFCQALVAAV | 1321 | Q8TCU6 | |
| FHVRCERRDSKVEVI | 1416 | Q13635 | |
| KACEVVVRQREREAH | 611 | O43147 | |
| FHITIDIRNVCVFLA | 106 | P46977 | |
| RQHEVCCQDVVVKLR | 936 | Q149N8 | |
| TQQILEVHLVRFCVR | 831 | Q6ZUB1 | |
| VRCIRHILYNEQRLV | 106 | P51692 | |
| IHHRFVRDEIQCVIA | 806 | Q14191 | |
| IAHERLTVLIFLEDC | 531 | Q8TBZ3 | |
| VEILRDIICRSHFQY | 86 | Q8WU76 | |
| ELCTRHQVLFIADEI | 251 | P04181 | |
| AEVHRHQAVCVDLVR | 686 | Q9NRC6 | |
| VRCIRHILYNEQRLV | 106 | P42229 | |
| VVREVCRSHVRIAEA | 241 | Q9GZX3 | |
| IAVFLCIHIVLRFRN | 441 | Q8N1B4 | |
| VVEDVKFRAHRCVLA | 41 | O43829 | |
| VCRTKEAEFQRHVLQ | 421 | Q7Z2Z1 | |
| LEEIHIFVLCNILRR | 191 | P21580 | |
| ELRAAEVVVCFQLRH | 966 | Q96PX9 | |
| ACVNSEEIVRLLIEH | 211 | Q9H1D0 | |
| RNVNGVDRLCVLHVE | 151 | Q4G0T1 | |
| RLVVVAEHCERSLED | 66 | Q8TEA7 | |
| LLIRCILEHAVNFED | 246 | Q8IYL9 | |
| HELVTRALQLVQFDC | 36 | Q8N2W9 | |
| HCLRSVDNLFVVVQE | 86 | Q9BV44 | |
| LCDITLIVENVHFRA | 36 | O43167 | |
| VAFTQRKAVIHERVC | 176 | Q9UJW8 | |
| RAAVVIQAHVRSFLC | 31 | Q7Z3V4 | |
| ALVCFEKRLVVAHEL | 936 | Q96AY4 | |
| LQHCLETVREEFIIF | 351 | Q9NY57 | |
| ILVYRAHRIIESCQE | 131 | Q92889 | |
| AHRIIESCQEAFILR | 136 | Q92889 | |
| RAVRHCVRAFLEQIG | 61 | O60294 | |
| ALELAVDQREIQHVC | 341 | Q8N584 | |
| AIEIEERRIQSCVHF | 81 | Q13769 | |
| EQLRVFREHRGSVIC | 226 | Q86TI4 | |
| IAACQVLIFREIHAS | 221 | P30518 | |
| ACVNSEEIVRLLIEH | 171 | Q9NQA5 |